Public Meeting of the Presidential Commission for the Study of Bioethical Issues, 24947 [2015-10205]

Download as PDF Federal Register / Vol. 80, No. 84 / Friday, May 1, 2015 / Notices William Kohn, DDS (former Panel member), Director (2010–11), Division of Oral Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services Arlene M. Lester, DDS, MPH, CAPT, United States Public Health Service, Regional Minority Health Consultant, Office of the Secretary, US Department of Health and Human Services Nicholas S. Makrides, DMD, MA, MPH, Assistant Surgeon General, Chief Dental Officer, United States Public Health Service, Chief Dentist, Federal Bureau of Prisons, U.S. Department of Justice Richard Manski, DDS, MBA, Ph.D., Senior Scholar, Center for Financing, Access and Cost Trends, Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services Ana Maria Osorio, MD, MPH, Senior Advisor for the Public Health Service, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services Benson Silverman, MD (former panel member, deceased), Staff Director, Infant Formula and Medical Foods, Center for Food Safety and Applied Nutrition, Food and Drug Administration, U.S. Department of Health and Human Services Thomas Sinks, Ph.D., Deputy Director, National Center for Environmental Health/ Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services [FR Doc. 2015–10201 Filed 4–30–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Meeting of the Presidential Commission for the Study of Bioethical Issues Presidential Commission for the Study of Bioethical Issues, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice of meeting. AGENCY: The Presidential Commission for the Study of Bioethical Issues (the Commission) will conduct its twentyfirst meeting on May 27, 2015. At this meeting, the Commission will discuss the role of deliberation and deliberative methods to engage the public and inform debate in bioethics, and how to integrate pubic dialogue into the bioethics conversation; bioethics education as a forum for fostering deliberative skills, and preparing students to participate in public dialogue in bioethics; goals and methods of bioethics education; and integrating bioethics education across a mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:14 Apr 30, 2015 Jkt 235001 range of professional disciplines and educational levels. DATES: The meeting will take place Wednesday, May 27, 2015, from 9 a.m. to approximately 5 p.m. ADDRESSES: University of Pennsylvania Henry Jordan Medical Education Center, 5th Floor Lobby, 3400 Civic Center Boulevard, Philadelphia, PA 19104. FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications Director, Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue NW., Suite C–100, Washington, DC 20005. Telephone: 202–233–3960. Email: Hillary.Viers@ bioethics.gov. Additional information may be obtained at www.bioethics.gov. SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee Act of 1972, Public Law 92–463, 5 U.S.C. app. 2, notice is hereby given of the twenty-first meeting of the Commission. The meeting will be open to the public with attendance limited to space available. The meeting will also be webcast at www.bioethics.gov. Under authority of E. O. 13521, dated November 24, 2009, the President established the Commission. The Commission is an expert panel of not more than 13 members who are drawn from the fields of bioethics, science, medicine, technology, engineering, law, philosophy, theology, or other areas of the humanities or social sciences. The Commission advises the President on bioethical issues arising from advances in biomedicine and related areas of science and technology. The Commission seeks to identify and promote policies and practices that ensure scientific research, health care delivery, and technological innovation are conducted in a socially and ethically responsible manner. The main agenda items for the Commission’s twenty-first meeting are to discuss the role of deliberation and deliberative methods to engage the public and inform debate in bioethics, and how to integrate pubic dialogue into the bioethics conversation; bioethics education as a forum for fostering deliberative skills, and preparing students to participate in public dialogue in bioethics; goals and methods of bioethics education; and integrating bioethics education across a range of professional disciplines and educational levels. The draft meeting agenda and other information about the Commission, including information about access to the webcast, will be available at www.bioethics.gov. The Commission welcomes input from anyone wishing to provide public comment on any issue before it. PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 24947 Respectful debate of opposing views and active participation by citizens in public exchange of ideas enhances overall public understanding of the issues at hand and conclusions reached by the Commission. The Commission is particularly interested in receiving comments and questions during the meeting that are responsive to specific sessions. Written comments will be accepted at the registration desk and comment forms will be provided to members of the public in order to write down questions and comments for the Commission as they arise. To accommodate as many individuals as possible, the time for each question or comment may be limited. If the number of individuals wishing to pose a question or make a comment is greater than can reasonably be accommodated during the scheduled meeting, the Commission may make a random selection. Written comments will also be accepted in advance of the meeting and are especially welcome. Please address written comments by email to info@ bioethics.gov, or by mail to the following address: Public Commentary, Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue NW., Suite C–100, Washington, DC 20005. Comments will be publicly available, including any personally identifiable or confidential business information that they contain. Trade secrets should not be submitted. Anyone planning to attend the meeting who needs special assistance, such as sign language interpretation or other reasonable accommodations, should notify Esther Yoo by telephone at (202) 233–3960, or email at Esther.Yoo@bioethics.gov in advance of the meeting. The Commission will make every effort to accommodate persons who need special assistance. Dated: April 22, 2015. Lisa M. Lee, Executive Director, Presidential Commission for the Study of Bioethical Issues. [FR Doc. 2015–10205 Filed 4–30–15; 8:45 am] BILLING CODE 4154–06–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. E:\FR\FM\01MYN1.SGM 01MYN1

Agencies

[Federal Register Volume 80, Number 84 (Friday, May 1, 2015)]
[Notices]
[Page 24947]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-10205]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Meeting of the Presidential Commission for the Study of 
Bioethical Issues

AGENCY: Presidential Commission for the Study of Bioethical Issues, 
Office of the Assistant Secretary for Health, Office of the Secretary, 
Department of Health and Human Services.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Presidential Commission for the Study of Bioethical Issues 
(the Commission) will conduct its twenty-first meeting on May 27, 2015. 
At this meeting, the Commission will discuss the role of deliberation 
and deliberative methods to engage the public and inform debate in 
bioethics, and how to integrate pubic dialogue into the bioethics 
conversation; bioethics education as a forum for fostering deliberative 
skills, and preparing students to participate in public dialogue in 
bioethics; goals and methods of bioethics education; and integrating 
bioethics education across a range of professional disciplines and 
educational levels.

DATES: The meeting will take place Wednesday, May 27, 2015, from 9 a.m. 
to approximately 5 p.m.

ADDRESSES: University of Pennsylvania Henry Jordan Medical Education 
Center, 5th Floor Lobby, 3400 Civic Center Boulevard, Philadelphia, PA 
19104.

FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications 
Director, Presidential Commission for the Study of Bioethical Issues, 
1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Telephone: 
202-233-3960. Email: Hillary.Viers@bioethics.gov. Additional 
information may be obtained at www.bioethics.gov.

SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee 
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given 
of the twenty-first meeting of the Commission. The meeting will be open 
to the public with attendance limited to space available. The meeting 
will also be webcast at www.bioethics.gov.
    Under authority of E. O. 13521, dated November 24, 2009, the 
President established the Commission. The Commission is an expert panel 
of not more than 13 members who are drawn from the fields of bioethics, 
science, medicine, technology, engineering, law, philosophy, theology, 
or other areas of the humanities or social sciences. The Commission 
advises the President on bioethical issues arising from advances in 
biomedicine and related areas of science and technology. The Commission 
seeks to identify and promote policies and practices that ensure 
scientific research, health care delivery, and technological innovation 
are conducted in a socially and ethically responsible manner.
    The main agenda items for the Commission's twenty-first meeting are 
to discuss the role of deliberation and deliberative methods to engage 
the public and inform debate in bioethics, and how to integrate pubic 
dialogue into the bioethics conversation; bioethics education as a 
forum for fostering deliberative skills, and preparing students to 
participate in public dialogue in bioethics; goals and methods of 
bioethics education; and integrating bioethics education across a range 
of professional disciplines and educational levels. The draft meeting 
agenda and other information about the Commission, including 
information about access to the webcast, will be available at 
www.bioethics.gov.
    The Commission welcomes input from anyone wishing to provide public 
comment on any issue before it. Respectful debate of opposing views and 
active participation by citizens in public exchange of ideas enhances 
overall public understanding of the issues at hand and conclusions 
reached by the Commission. The Commission is particularly interested in 
receiving comments and questions during the meeting that are responsive 
to specific sessions. Written comments will be accepted at the 
registration desk and comment forms will be provided to members of the 
public in order to write down questions and comments for the Commission 
as they arise. To accommodate as many individuals as possible, the time 
for each question or comment may be limited. If the number of 
individuals wishing to pose a question or make a comment is greater 
than can reasonably be accommodated during the scheduled meeting, the 
Commission may make a random selection.
    Written comments will also be accepted in advance of the meeting 
and are especially welcome. Please address written comments by email to 
info@bioethics.gov, or by mail to the following address: Public 
Commentary, Presidential Commission for the Study of Bioethical Issues, 
1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Comments 
will be publicly available, including any personally identifiable or 
confidential business information that they contain. Trade secrets 
should not be submitted.
    Anyone planning to attend the meeting who needs special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify Esther Yoo by telephone at (202) 233-
3960, or email at Esther.Yoo@bioethics.gov in advance of the meeting. 
The Commission will make every effort to accommodate persons who need 
special assistance.

    Dated: April 22, 2015.
Lisa M. Lee,
Executive Director, Presidential Commission for the Study of Bioethical 
Issues.
[FR Doc. 2015-10205 Filed 4-30-15; 8:45 am]
 BILLING CODE 4154-06-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.